CS logo
small CS logo
CTSU, University of Oxford

Oxford, Oxfordshire, United Kingdom

About CTSU, University of Oxford


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender

Clinical Trials at CTSU, University of Oxford


During the past decade, CTSU, University of Oxford conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 1 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Clinical Trials Sponsors and Collaborators


In terms of collaborators to trials, out of the total clinical trials conducted in "CTSU, University of Oxford" #1 collaborator was "AstraZeneca" with 1 trials as a collaborator, "Cancer Institute and Hospital, Chinese Academy of Medical Sciences" with 1 trials as a collaborator, "Merck Institute for Therapeutic Research" with 1 trials as a collaborator, "Merck Sharp & Dohme LLC" with 1 trials as a collaborator and "Novartis Pharmaceuticals" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.

Clinical Trials Conditions at CTSU, University of Oxford


According to Clinical.Site data, the most researched conditions in "CTSU, University of Oxford" are "Atherosclerotic Cardiovascular Disease" (2 trials), "Acute Myocardial Infarction" (1 trials), "Hepatitis B" (1 trials), "Liver Diseases" (1 trials) and "Liver Neoplasms" (1 trials). Many other conditions were trialed in "CTSU, University of Oxford" in a lesser frequency.

Clinical Trials Intervention Types at CTSU, University of Oxford


Most popular intervention types in "CTSU, University of Oxford" are "Drug" (3 trials) and "Biological" (1 trials). Other intervention types were less common.
The name of intervention was led by "Anacetrapib" (1 trials), "Hep-V Vax" (1 trials), "Inclisiran" (1 trials), "Placebo" (1 trials) and "Placebo anacetrapib" (1 trials). Other intervention names were less common.

Clinical Trials Genders at CTSU, University of Oxford


The vast majority of trials in "CTSU, University of Oxford" are 4 trials for "All" genders.

Clinical Trials Status at CTSU, University of Oxford


Currently, there are NaN active trials in "CTSU, University of Oxford". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in CTSU, University of Oxford, undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in CTSU, University of Oxford, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".